Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Applied Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 733K | $3.95M | $5.39 | Mar 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APLT | Applied Therapeutics, Inc. | Mar 14, 2024 | 1 | -$263K | 4 | Mar 18, 2024 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 22, 2023 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Nov 30, 2023 | 1 | -$1.9K | 4 | Dec 1, 2023 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Sep 27, 2023 | 1 | -$26.2K | 4 | Sep 29, 2023 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Jan 11, 2023 | 2 | -$4.09K | 4 | Jan 13, 2023 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Aug 2, 2022 | 10 | $0 | 4 | Aug 4, 2022 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Apr 13, 2022 | 1 | $0 | 4 | Apr 15, 2022 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Jan 7, 2022 | 2 | $0 | 4 | Jan 11, 2022 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | Dec 14, 2021 | 1 | $0 | 4/A | Jan 11, 2022 | Chief Commercial Officer |
APLT | Applied Therapeutics Inc. | May 26, 2021 | 1 | -$53.1K | 4 | May 28, 2021 | Chief Commercial Officer |